The impact of the rare disease and Orphan Drug Act in Taiwan

The Rare Disease and Orphan Drug Act (the Act) was enacted in 2000 in Taiwan for the facilitation of the research, development, and accessibility of orphan drugs and special nutritional foods; for the prevention and early diagnosis of rare diseases; and for providing intensive care for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsiang, Ning-Chun, Huang, Weng-Foung, Gau, Churn-Shiouh, Tsai, Teng-Wen, Chang, Lin-Chau
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taiwan Food and Drug Administration 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931014/
https://www.ncbi.nlm.nih.gov/pubmed/35649145
http://dx.doi.org/10.38212/2224-6614.3383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931014/
https://www.ncbi.nlm.nih.gov/pubmed/35649145
http://dx.doi.org/10.38212/2224-6614.3383

Ejemplares similares